Marc-henri F. Stern
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 137 publications
Prevalence of the Predisposing Gene MBD4 for Uveal Melanoma.
Journal: JAMA ophthalmology
Published: April 30, 2026
Integrative screening identifies functional variants and VNTRs underlying GWAS signals at the 5p15.33 multi-cancer susceptibility locus.
Journal: medRxiv : the preprint server for health sciences
Published: March 23, 2026
Human PMS1-dependent non-canonical mismatch repair engages with MBD4 to repair methylated CpG deamination.
Journal: Nucleic acids research
Published: February 24, 2026
Total tumor volume and growth rate at 3 months on MRI outperform baseline imaging and circulating tumor DNA for predicting survival of patients with metastatic uveal melanoma receiving tebentafusp.
Journal: Diagnostic and interventional imaging
Published: December 09, 2025
BARD1 and breast cancer genetic predisposition: case-control study and HRD signature analysis.
Journal: Breast cancer (Tokyo, Japan)
Published: December 05, 2025
GWAS meta-analysis provides new insights into uveal melanoma risk.
Journal: British journal of cancer
Published: December 04, 2025
Genetic Background Predicts Uveal Melanoma Patients' Outcomes.
Journal: Ophthalmology science
Published: September 16, 2025
Uveal Melanoma and the Lynch Syndrome Tumor Spectrum.
Journal: JAMA ophthalmology
Published: June 18, 2025
Meta-analysis of uveal melanoma genome-wide association studies identifies novel risk loci and population effect size heterogeneity.
Journal: HGG advances
Published: February 04, 2025
Safety and Potential Radiosensitizing Effect of Olaparib in Combination With Breast Radiation Therapy for Patients With Triple-Negative Breast Cancer With Residual Disease: Long-Term Results From the RADIOPARP Phase 1 Trial.
Journal: International journal of radiation oncology, biology, physics
Published: January 27, 2025
Last Updated: 09/26/2026